Pharmaceutical combined preparations containing erythropoietin and iron preparations
CA 2284910 C · Owner: Roche Diagnostics Gmbh · Inventors: Lehmann, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a pharmaceutical combined preparation comprising 250 - 20,000 U of an EPO preparation in an individual form of administration and 5- 20 mg of an Fe(III) complex. Said EPO preparation and said Fe(III) complex can be made available in a separate or homogeneous form of administration. Said pharmaceutical preparation is used for treating anemic or hemodialysis patients.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 18, 1997 and granted January 28, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 18, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 18, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.